West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
wst · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$340
Consensus
$316
+0.4% upside
Low
$295
Median: $315 · Last Close: $314.50
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$315.83
0.4% upside
High Target
$340
8.1%
Low Target
$295
-6.2%
Current Price
$314.50
as of today
Based on analyst price targets, the WST stock price prediction for the next 12 months ranges from $295 to $340. The consensus WST price forecast of $315.83 implies 0.4% upside from the current price of $314.50.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $316.15 | ↑ 0.52% |
1-day model range: $315.13–$317.17. Peak: $317.17 (+0.52%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $343 | +9.1% |
| 2028 | $364 | +15.6% |
| 2029 | $378 | +20.0% |
| 2030 | $387 | +23.0% |
| 2031 | — | +25.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · WST · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2026-05-29 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-04-27 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-04-14 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-02-13 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-02-03 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-10-27 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2025-10-24 | Keybanc | Maintains | Overweight→Overweight |
| 2025-10-24 | UBS | Maintains | Buy→Buy |
| 2025-10-23 | Evercore ISI Group | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on West Pharmaceutical Services, Inc. (WST) stock. Of the recent 71 rating actions, 9 were upgrades and 9 were downgrades. 15 analysts currently cover WST.
Analyst Recommendation Trends
WST analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3.3B
↓ 11.7% YoY
Revenue Next Year
$3.5B
↑ 6.1% YoY
EPS This Year
$8.61
EPS Next Year
$9.56
↑ 11.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast WST EPS of $8.61 for the current fiscal year, based on estimates from 9 analysts. The WST revenue forecast is $3.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The WST stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus WST price target is $315.83 (+0.4% upside), with an analyst consensus of Buy.
The WST short-term stock prediction for tomorrow is $316.15 (+0.52%). The WST stock price prediction for 2027 estimates an average of $343. The WST stock prediction for 2030 projects a range of $373–$401.
West Pharmaceutical Services, Inc. trades on NYSE under the ticker WST. The WST stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
WST forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month WST price target is $315.83, with a high forecast of $340.00 and a low of $295.00. The median price target is shown in the chart above when available. This implies +0.4% potential upside from the current price of $314.50.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.